Indication
Necrobiosis lipoidica diabeticorum
Necrobiosis lipoidica diabeticorum is a rare, chronic granulomatous skin disease classically associated with diabetes mellitus, particularly affecting young-to-middle-aged adults and exhibiting a marked female predominance. Read more about Necrobiosis lipoidica diabeticorum
8 drugs 5 manufacturers
Drugs that treat it
Common Necrobiosis lipoidica diabeticorum therapies.
KENALOG-10 (triamcinolone acetonide)
ARISTOSPAN (triamcinolone hexacetonide)
ARISTOSPAN (triamcinolone hexacetonide)
KENALOG (triamcinolone acetonide)
HEXATRIONE (triamcinolone hexacetonide)
KENALOG-10 (triamcinolone acetonide)
TRIAMCINOLONE ACETONIDE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNecrobiosis lipoidica diabeticorum is a rare, chronic granulomatous skin disease classically associated with diabetes mellitus, particularly affecting young-to-middle-aged adults and exhibiting a marked female predominance.
It typically presents on the pretibial surfaces of the lower extremities as well-demarcated, yellowish-brown plaques characterized by raised violaceous borders, central epidermal atrophy, and prominent overlying telangiectasias.
Pathophysiologically, the condition is driven by microangiopathic changes, granulomatous inflammation, collagen degeneration (necrobiosis), and lipid deposition within the dermis and subcutaneous tissue.
Due to marked tissue fragility, affected plaques frequently suffer painful ulcerations following minor trauma and can rarely undergo malignant transformation into squamous cell carcinoma.
- nih.gov
Necrobiosis lipoidica diabeticorum is a rare, chronic granulomatous skin disease classically associated with diabetes mellitus, particularly affecting young-to-middle-aged adults and exhibiting a marked female predominance Pathophysiologically, the condition is driven by microangiopathic changes, granulomatous inflammation, collagen degeneration (necrobiosis), and lipid deposition within the dermis and subcutaneous tissue Due to marked tissue fragility, affected plaques frequently suffer painful...
- nih.gov
Necrobiosis lipoidica diabeticorum is a rare, chronic granulomatous skin disease classically associated with diabetes mellitus, particularly affecting young-to-middle-aged adults and exhibiting a marked female predominance It typically presents on the pretibial surfaces of the lower extremities as well-demarcated, yellowish-brown plaques characterized by raised violaceous borders, central epidermal atrophy, and prominent overlying telangiectasias Due to marked tissue fragility, affected plaques ...
- nih.gov
Necrobiosis lipoidica diabeticorum is a rare, chronic granulomatous skin disease classically associated with diabetes mellitus, particularly affecting young-to-middle-aged adults and exhibiting a marked female predominance
- nih.gov
It typically presents on the pretibial surfaces of the lower extremities as well-demarcated, yellowish-brown plaques characterized by raised violaceous borders, central epidermal atrophy, and prominent overlying telangiectasias
- nih.gov
Pathophysiologically, the condition is driven by microangiopathic changes, granulomatous inflammation, collagen degeneration (necrobiosis), and lipid deposition within the dermis and subcutaneous tissue
Personalize your experience
Follow Necrobiosis lipoidica diabeticorum and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.